FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 93 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,000 | +40.0% | 352 | -51.2% | 0.00% | – |
| Q2 2022 | $5,000 | -84.8% | 722 | -79.3% | 0.00% | – |
| Q1 2022 | $33,000 | -85.8% | 3,481 | -78.7% | 0.00% | – |
| Q4 2021 | $232,000 | +32.6% | 16,376 | +117.4% | 0.00% | – |
| Q3 2021 | $175,000 | -85.4% | 7,534 | -84.3% | 0.00% | – |
| Q2 2021 | $1,198,000 | +2895.0% | 48,101 | +3311.4% | 0.00% | – |
| Q1 2021 | $40,000 | -95.3% | 1,410 | -94.3% | 0.00% | – |
| Q4 2020 | $857,000 | +40.7% | 24,559 | +101.2% | 0.00% | – |
| Q3 2020 | $609,000 | – | 12,208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,529 | $43,866,000 | 8.09% |
| Logos Global Management LP | 1,410,000 | $39,508,000 | 3.86% |
| RA Capital Management | 9,011,651 | $252,506,000 | 3.81% |
| Cormorant Asset Management, LP | 4,720,000 | $132,254,000 | 2.95% |
| Artal Group S.A. | 1,000,000 | $28,020,000 | 0.50% |
| Perceptive Advisors | 1,250,000 | $35,025,000 | 0.44% |
| HighVista Strategies LLC | 20,630 | $578,000 | 0.43% |
| HHLR ADVISORS, LTD. | 1,100,000 | $30,822,000 | 0.30% |
| Baker Brothers Advisors | 2,024,876 | $56,737,000 | 0.25% |
| Tekla Capital Management LLC | 149,825 | $4,198,000 | 0.14% |